Skip to main content

Published locations for FDA approves tenofovir alafenamide for patients with chronic hepatitis B and liver disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves tenofovir alafenamide for patients with chronic hepatitis B and liver disease

User login

  • Reset your password
  • /content/fda-approves-tenofovir-alafenamide-patients-chronic-hepatitis-b-and-liver-disease
  • /familypracticenews/article/117917/hepatology/fda-approves-tenofovir-alafenamide-patients-chronic
  • /gihepnews/article/117917/hepatology/fda-approves-tenofovir-alafenamide-patients-chronic-hepatitis-b
  • /idpractitioner/article/117917/hepatology/fda-approves-tenofovir-alafenamide-patients-chronic
  • /internalmedicinenews/article/117917/hepatology/fda-approves-tenofovir-alafenamide-patients-chronic
  • /infectiousdisease/article/117917/hepatology/fda-approves-tenofovir-alafenamide-patients-chronic
  • /internalmedicine/article/117917/hepatology/fda-approves-tenofovir-alafenamide-patients-chronic
  • /familymedicine/article/117917/hepatology/fda-approves-tenofovir-alafenamide-patients-chronic